As of 2026-04-20, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -0.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is 40.44 mil USD. FBIO's TTM EBITDA according to its financial statements is -66.56 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 14.1x | 14.0x |
| Forward P/E multiples | 17.7x - 21.1x | 20.0x |
| Fair Price | (36.94) - (29.22) | (35.40) |
| Upside | -1665.3% - -1338.2% | -1599.9% |
| Date | EV/EBITDA |
| 2026-04-17 | -0.61 |
| 2026-04-16 | -0.60 |
| 2026-04-15 | -0.64 |
| 2026-04-14 | -0.64 |
| 2026-04-13 | -0.64 |
| 2026-04-10 | -0.60 |
| 2026-04-09 | -0.63 |
| 2026-04-08 | -0.58 |
| 2026-04-07 | -0.60 |
| 2026-04-06 | -0.68 |
| 2026-04-02 | -0.72 |
| 2026-04-01 | -0.66 |
| 2026-03-31 | -0.81 |
| 2026-03-30 | -0.77 |
| 2026-03-27 | -0.79 |
| 2026-03-26 | -0.85 |
| 2026-03-25 | -0.90 |
| 2026-03-24 | -0.87 |
| 2026-03-23 | -0.90 |
| 2026-03-20 | -0.90 |
| 2026-03-19 | -0.97 |
| 2026-03-18 | -0.98 |
| 2026-03-17 | -0.96 |
| 2026-03-16 | -0.95 |
| 2026-03-13 | -0.95 |
| 2026-03-12 | -1.04 |
| 2026-03-11 | -1.01 |
| 2026-03-10 | -1.07 |
| 2026-03-09 | -1.08 |
| 2026-03-06 | -1.06 |
| 2026-03-05 | -0.97 |
| 2026-03-04 | -0.95 |
| 2026-03-03 | -0.93 |
| 2026-03-02 | -1.05 |
| 2026-02-27 | -1.10 |
| 2026-02-26 | -1.15 |
| 2026-02-25 | -1.16 |
| 2026-02-24 | -1.16 |
| 2026-02-23 | -1.12 |
| 2026-02-20 | -1.07 |
| 2026-02-19 | -1.13 |
| 2026-02-18 | -1.12 |
| 2026-02-17 | -1.14 |
| 2026-02-13 | -1.19 |
| 2026-02-12 | -1.13 |
| 2026-02-11 | -1.22 |
| 2026-02-10 | -1.26 |
| 2026-02-09 | -1.21 |
| 2026-02-06 | -1.03 |
| 2026-02-05 | -0.87 |